Hire Automation Expert for Biotech Startups
Senior, direct, no layers

A biotech startup runs on experiments, data, and milestones: assays to validate, CRO studies to oversee, investor updates to write, and a regulatory path that must be documented from the earliest work. Data scattered across notebooks and inboxes slows every one of those.

An automation expert connects the systems an organization already runs so work stops being retyped, rechecked, and chased by hand. For biotech startups, that means assay development and validation moving between an electronic lab notebook such as Benchling and a LIMS without manual handoffs, with a human check wherever the stakes are high.

Picture a CRO dataset arriving in a format nobody can use, days before an investor update is due. In that situation, an automated handoff that pulls the scattered details into an electronic lab notebook such as Benchling, flags what is missing, and routes exceptions to a named person would remove the manual scramble entirely. Book a free discovery call and we will test the fit on one real workflow before any wider scope is agreed.

The stack here is an electronic lab notebook such as Benchling, a LIMS, bioinformatics pipelines, and CRO data portals. The gap is usually connection, not tools: work lands in one system, records live in another, and nobody has one view of where a case stands. This engagement connects that stack and standardises the routines around it.

The automation sits between an electronic lab notebook such as Benchling and a LIMS, using their existing interfaces rather than replacing either tool. Each routine logs what it moved, so the team can audit any case end to end.

This page describes services, not scientific or regulatory advice. Research and regulatory decisions stay with the startup's qualified scientific staff. FDA IND and BLA pathways shapes what can be automated or changed, and the work is scoped to fit it rather than work around it.

The realistic outcome is data the team can actually use: experiments findable, CRO results comparable, and updates assembled from real results instead of rebuilt each time.

Two problems deserve naming: experimental data scattered across notebooks and drives and CRO results arriving late or in unusable formats. Both persist when the underlying routine stays manual and nobody owns the follow-up, so each deliverable in this engagement is paired with a named owner and a visible queue, and problems surface while they are still small.

What changes is the middle of the day: less copying, fewer chase messages, and a visible queue of what is actually outstanding.

Browse all hire engagements or discuss your biotech startup workflow directly.